Effects of Melatonin Treatment on Perioperative Sleep Quality: A Systematic Review and Meta-Analysis with Trial Sequential Analysis of Randomized Controlled Trials
Yi Gao,Xuezhao Chen,Qi Zhou,Jiannan Song,Xizhe Zhang,Yi Sun,Miao Yu,Yun Li
DOI: https://doi.org/10.2147/NSS.S381918
2022-09-24
Nature and Science of Sleep
Abstract:Yi Gao 1 &ast, Xuezhao Chen 2 &ast, Qi Zhou, 1, 3 Jiannan Song, 1, 3 Xizhe Zhang, 1, 3 Yi Sun, 1, 3 Miao Yu, 1, 3 Yun Li 1, 3 1 Chifeng Clinical Medical College of Inner Mongolia Medical University, Chifeng, People's Republic of China; 2 First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China; 3 Department of Anesthesiology, Chifeng Municipal Hospital, Chifeng, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yun Li, Chifeng Municipal Hospital, Hongshan, Chifeng, Inner Mongolia Autonomous Region, People's Republic of China, Tel +86 188 4760 0734, Email Purpose: Perioperative sleep disorders have attracted much attention due to their high prevalence and severe harm, and the current treatment methods are insufficient. Some randomized controlled trials (RCTs) have produced controversial results on whether melatonin can improve perioperative sleep quality. This review aimed to evaluate the effects of melatonin treatment on perioperative sleep quality. Patients and Methods: A systematic search of six databases was performed to identify RCTs investigating melatonin and perioperative sleep. The outcomes analyzed were subjective sleep quality, sleep latency (SL), total sleep time (TST), sleep efficiency (SE), the behavior of awakenings and daily naps, and the incidence of poor sleep quality. RevMan 5.4 and Stata 16 software was used for the meta-analysis and sensitivity analysis, and trial sequential analysis was conducted using TSA 0.9.5.10 Beta software. This study was registered in PROSPERO (registration number: CRD42022311378). Results: 10 studies containing 725 participants were included. Melatonin improved postoperative subjective sleep quality (SMD: − 0.30; 95% CI: [− 0.47, − 0.14]; P = 0.0004) but not preoperative sleep quality (MD: − 2.76; 95% CI: [− 10.44, 4.91]; P = 0.48). In the postoperative period, 6mg dose had the best efficacy (SMD: − 0.31; 95% CI: [− 0.57, − 0.04]; P = 0.02). Melatonin increased postoperative TST (P = 0.02) and SE (P = 0.002) and decreased the incidence of postoperative poor sleep quality (P = 0.002) but had no effect on SL (P = 0.11), the number and duration of awakenings (P = 0.28; P=0.55), and the number and duration of daily naps (P = 0.26; P = 0.38). The trial sequential analysis showed that the accumulated Z value crossed both the traditional boundary value and the TSA boundary value, further confirming the stability of the result of the meta-analysis. Conclusion: Melatonin treatment can improve postoperative sleep quality. A 6mg daily dose of melatonin may have a better beneficial effect, which needs further exploration. This study supports the application of melatonin for improving postoperative sleep quality. Keywords: melatonin, sleep quality, perioperative, preoperative, postoperative, meta-analysis Perioperative sleep disorders have become a significant challenge in the current medical environment due to their high prevalence, with estimates ranging from 64% to 73.1%. 1–3 Perioperative sleep disorders may contribute to a variety of serious postoperative complications. The common complications include postoperative neurocognitive disorder (PND), postoperative delirium, postoperative pain exacerbation, and sensitization. 1,4–7 In addition, mood disorders and other psychological problems, cardiovascular disorders, metabolic impairment, and immune disorders can also occur. 4,6 More than that, the length of hospital stay will be extended, and the prognosis of surgical patients will be affected. 8,9 However, there is still no definite treatment for perioperative sleep disorders. Treatments that focus on the sleep environment and mood are usually influenced by multiple factors. Traditional drug treatment, such as benzodiazepines, is often limited due to the noticeable adverse reactions. 4,6 Although acupuncture has emerged in recent years, it needs to be further confirmed by large-scale trials owing to limited efficacy and lack of evidence. 10 Thus, there is an urgent need for a drug with a definite sleep-promoting effect and fewer adverse reactions to improve perioperative sleep quality. Melatonin (n acetyl 5 methoxytryptamine), an indoleamine produced by the pineal gland, is the neuroendocrine basis for regulating sleep and has a variety of other physiological functions (such as modulating blood pressure, body temperature, immune and metabolic function). 11–13 Studies have supported the clinical application of perioperative melatonin as a treatment for sleep disor -Abstract Truncated-
neurosciences,clinical neurology